Cecilia Godoy Carvalhaes (Cecilia Carvalhaes, C G Carvalhaes, Cecilia G Carvalhaes)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 40

Top Topics

Acinetobacter Baumannii

Multidrug Resistant

Genetic Diversity

Candida Albicans

Top Venues

Journal of clinical microbiology

Journal of fungi (Basel, Switzerland)

Microbiology spectrum

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Cecilia Godoy Carvalhaes, Paul R Rhomberg, Michael D Huband, Michael A Pfaller, Mariana Castanheira
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum 11 (1) (2023)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Mariana Castanheira
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity. Mycoses (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, Cecilia Godoy Carvalhaes, John H Kimbrough, Mariana Castanheira
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021). Open forum infectious diseases 10 (2) (2023)
Michael A Pfaller, Dee Shortridge, Cecilia Godoy Carvalhaes, Mariana Castanheira
Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021. Microbiology spectrum (2023)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Lalitagauri M Deshpande, Paul R Rhomberg, Mariana Castanheira
In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations. Journal of fungi (Basel, Switzerland) 9 (6) (2023)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Lalitagauri M Deshpande, Paul R Rhomberg, Mariana Castanheira
In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations. Journal of fungi (Basel, Switzerland) 9 (6) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum (2023)
Michael A Pfaller, Rodrigo Elisandro Mendes, Helio Silva Sader, Mariana Castanheira, Cecilia Godoy Carvalhaes
Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019). Journal of chemotherapy (Florence, Italy) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum 11 (1) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, Cecilia Godoy Carvalhaes, John H Kimbrough, Mariana Castanheira
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021). Open forum infectious diseases 10 (2) (2023)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Lalitagauri M Deshpande, Paul R Rhomberg, Mariana Castanheira
In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations. Journal of fungi (Basel, Switzerland) 9 (6) (2023)
Cecilia Godoy Carvalhaes, Paul R Rhomberg, Michael D Huband, Michael A Pfaller, Mariana Castanheira
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum 11 (1) (2023)
Cecilia Godoy Carvalhaes, Paul R Rhomberg, Michael D Huband, Michael A Pfaller, Mariana Castanheira
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Jennifer M Streit, Rodrigo E Mendes
Five-year analysis of the in vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programme. JAC-antimicrobial resistance 4 (5) (2022)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Sean DeVries, Michael D Huband, Mariana Castanheira
Plain language summary: Does a person's age affect how common fungal infections are and how well drugs can kill the infections? Future microbiology 17 (2022)
Cecilia Godoy Carvalhaes, Paul R Rhomberg, Michael A Pfaller, Jeffrey B Locke, Mariana Castanheira
Evaluation of the Post-Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata. Mycoses 65 (11) (2022)
Helio Silva Sader, Rodrigo Elisandro Mendes, S J Ryan Arends, Cecilia Godoy Carvalhaes, Mariana Castanheira
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (3) (2022)
Helio Silva Sader, Rodrigo E Mendes, Leonard R Duncan, Cecilia Godoy Carvalhaes, Mariana Castanheira
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19). The Journal of antimicrobial chemotherapy 77 (10) (2022)
Helio Silva Sader, Mariana Castanheira, Michael D Huband, Dee Shortridge, Cecilia Godoy Carvalhaes, Rodrigo Elisandro Mendes
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (5) (2022)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Sean DeVries, Paul Richard Rhomberg, Mariana Castanheira
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections. Medical mycology 60 (5) (2022)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Paul Richard Rhomberg, Mariana Castanheira, Sean DeVries, Rodrigo Elisandro Mendes
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019). The Pediatric infectious disease journal 41 (9) (2022)
Cecilia Godoy Carvalhaes, Abby L Klauer, Paul Richard Rhomberg, Michael A Pfaller, Mariana Castanheira
Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020). Journal of clinical microbiology 60 (4) (2022)
Helio S Sader, Jennifer M Streit, Cecilia Godoy Carvalhaes, Michael D Huband, Dee Shortridge, Rodrigo E Mendes, Mariana Castanheira
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19). JAC-antimicrobial resistance 3 (3) (2021)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Jennifer M Streit, Mariana Castanheira, Rodrigo Elisandro Mendes
Activity of Oritavancin Against Gram-positive Pathogens Causing Bloodstream Infections in the United States Over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019). Antimicrobial agents and chemotherapy (2021)
Dee Shortridge, Cecilia Godoy Carvalhaes, Lalitagauri Deshpande, Mariana Castanheira
Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014-19). The Journal of antimicrobial chemotherapy 76 (10) (2021)
Cecilia Godoy Carvalhaes, Paul R Rhomberg, Michael Pfaller, Mariana Castanheira
Comparative activity of posaconazole and systemic azole agents against clinical isolates of filamentous fungi from a global surveillance programme. JAC-antimicrobial resistance 3 (2) (2021)